Original Source(s)
Related Content
Stuart Therapeutics, Inc. Appoints Dave LeCause as Senior Commercial Advisor
New hire to commercialize a new class of collagen-reparative therapeutics
September 18, 2026
-
2 min
Nirsevimab may curb RSV severity
Real-world estimates showed protection across emergency, inpatient, and intensive care settings during Canada’s first universal immunization season.
September 18, 2026
-
3 min